ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines

Interferon (IFN) is effective at inducing complete remissions in patients with chronic myelogenous leukemia (CML), and evidence supports an immune mechanism. Here we show that the type I IFNs (alpha and beta) regulate expression of the IFN consensus sequence-binding protein (ICSBP) in BCR-ABL–transf...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nardi, Valentina, Naveiras, Olaia, Azam, Mohammad, Daley, George Q.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2009
Témata:
Myeloid Neoplasia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670796/
https://ncbi.nlm.nih.gov/pubmed/19171873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-167189
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky